Drugs / Mesenchymal Stem Cells Derived Exosomes
Mesenchymal Stem Cells Derived Exosomes
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06536712 | Aug → Oct 2024 overdue | rectal cancer | Tehran University of Medical Sciences | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Mesenchymal Stem Cells Derived Exosomes | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06536712 ↗ |
| Modality | Other / unclassified | “Mesenchymal Stem Cells Derived Exosomes” NCT06536712 ↗ |
| Route | Other | “administered intraperitoneally” NCT06536712 ↗ |